Atossa Therapeutics (ATOS) announced the appointment of Dr. Arezoo Mirad as Senior Medical Director. Prior to joining Atossa, Dr. Mirad served as Medical Director for Corcept Therapeutics (CORT).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ATOS:
- Atossa announces full enrollment of Phase 2 Karisma-Endoxifen trial
- Atossa Therapeutics Announces Full Enrollment of Phase 2 Karisma-Endoxifen Clinical Trial
- Atossa Therapeutics reports Q3 EPS (5c), consensus (7c)
- Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
- Atossa Therapeutics, Inc. (ATOS) Q3 Earnings Cheat Sheet
